vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and J.Jill, Inc. (JILL). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $150.5M, roughly 1.2× J.Jill, Inc.). J.Jill, Inc. runs the higher net margin — 6.1% vs 0.9%, a 5.2% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -0.5%). J.Jill, Inc. produced more free cash flow last quarter ($16.0M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 0.1%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
J.Jill is an American womenswear retailer founded in 1955 in Massachusetts. It has been a publicly traded company since 2017. J.Jill is headquartered in Quincy, Massachusetts.
FOLD vs JILL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $150.5M |
| Net Profit | $1.7M | $9.2M |
| Gross Margin | 85.7% | 70.9% |
| Operating Margin | 8.6% | 9.9% |
| Net Margin | 0.9% | 6.1% |
| Revenue YoY | 23.7% | -0.5% |
| Net Profit YoY | -88.5% | -25.5% |
| EPS (diluted) | $0.00 | $0.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $150.5M | ||
| Q3 25 | $169.1M | $154.0M | ||
| Q2 25 | $154.7M | $153.6M | ||
| Q1 25 | $125.2M | $142.8M | ||
| Q4 24 | $149.7M | $151.3M | ||
| Q3 24 | $141.5M | $155.2M | ||
| Q2 24 | $126.7M | $161.5M | ||
| Q1 24 | $110.4M | $150.3M |
| Q4 25 | $1.7M | $9.2M | ||
| Q3 25 | $17.3M | $10.5M | ||
| Q2 25 | $-24.4M | $11.7M | ||
| Q1 25 | $-21.7M | $2.2M | ||
| Q4 24 | $14.7M | $12.3M | ||
| Q3 24 | $-6.7M | $8.2M | ||
| Q2 24 | $-15.7M | $16.7M | ||
| Q1 24 | $-48.4M | $4.8M |
| Q4 25 | 85.7% | 70.9% | ||
| Q3 25 | 88.5% | 68.4% | ||
| Q2 25 | 90.2% | 71.8% | ||
| Q1 25 | 90.7% | 66.3% | ||
| Q4 24 | 90.1% | 71.4% | ||
| Q3 24 | 90.6% | 70.5% | ||
| Q2 24 | 91.1% | 72.9% | ||
| Q1 24 | 87.7% | 67.5% |
| Q4 25 | 8.6% | 9.9% | ||
| Q3 25 | 20.3% | 10.9% | ||
| Q2 25 | -6.1% | 12.4% | ||
| Q1 25 | -6.3% | 3.6% | ||
| Q4 24 | 10.7% | 12.7% | ||
| Q3 24 | 15.3% | 14.8% | ||
| Q2 24 | 11.8% | 17.6% | ||
| Q1 24 | -25.1% | 7.0% |
| Q4 25 | 0.9% | 6.1% | ||
| Q3 25 | 10.2% | 6.8% | ||
| Q2 25 | -15.8% | 7.6% | ||
| Q1 25 | -17.3% | 1.6% | ||
| Q4 24 | 9.8% | 8.2% | ||
| Q3 24 | -4.8% | 5.3% | ||
| Q2 24 | -12.4% | 10.3% | ||
| Q1 24 | -43.9% | 3.2% |
| Q4 25 | $0.00 | $0.60 | ||
| Q3 25 | $0.06 | $0.69 | ||
| Q2 25 | $-0.08 | $0.76 | ||
| Q1 25 | $-0.07 | $0.11 | ||
| Q4 24 | $0.05 | $0.80 | ||
| Q3 24 | $-0.02 | $0.54 | ||
| Q2 24 | $-0.05 | $1.16 | ||
| Q1 24 | $-0.16 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $58.0M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $129.0M |
| Total Assets | $949.9M | $458.0M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $58.0M | ||
| Q3 25 | $263.8M | $45.5M | ||
| Q2 25 | $231.0M | $31.2M | ||
| Q1 25 | $250.6M | $35.4M | ||
| Q4 24 | $249.9M | $38.8M | ||
| Q3 24 | $249.8M | $28.5M | ||
| Q2 24 | $260.1M | $77.1M | ||
| Q1 24 | $239.6M | $62.2M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $129.0M | ||
| Q3 25 | $230.4M | $121.5M | ||
| Q2 25 | $204.3M | $112.0M | ||
| Q1 25 | $193.6M | $105.8M | ||
| Q4 24 | $194.0M | $103.3M | ||
| Q3 24 | $178.8M | $90.4M | ||
| Q2 24 | $132.5M | $53.1M | ||
| Q1 24 | $130.7M | $37.2M |
| Q4 25 | $949.9M | $458.0M | ||
| Q3 25 | $868.8M | $436.5M | ||
| Q2 25 | $815.3M | $432.9M | ||
| Q1 25 | $789.8M | $417.7M | ||
| Q4 24 | $785.0M | $418.3M | ||
| Q3 24 | $786.6M | $390.8M | ||
| Q2 24 | $749.5M | $443.9M | ||
| Q1 24 | $721.8M | $428.2M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $19.1M |
| Free Cash FlowOCF − Capex | $16.0M | $16.0M |
| FCF MarginFCF / Revenue | 8.6% | 10.6% |
| Capex IntensityCapex / Revenue | 0.2% | 2.0% |
| Cash ConversionOCF / Net Profit | 9.62× | 2.07× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $37.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $19.1M | ||
| Q3 25 | $35.7M | $19.4M | ||
| Q2 25 | $-26.5M | $5.3M | ||
| Q1 25 | $7.8M | $8.1M | ||
| Q4 24 | $-3.9M | $19.1M | ||
| Q3 24 | $-23.0M | $16.4M | ||
| Q2 24 | $22.7M | $21.5M | ||
| Q1 24 | $-29.7M | $6.6M |
| Q4 25 | $16.0M | $16.0M | ||
| Q3 25 | $35.3M | $17.1M | ||
| Q2 25 | $-28.9M | $3.1M | ||
| Q1 25 | $7.5M | $1.4M | ||
| Q4 24 | $-4.2M | $14.6M | ||
| Q3 24 | $-23.3M | $15.0M | ||
| Q2 24 | $21.6M | $19.8M | ||
| Q1 24 | $-31.5M | $1.8M |
| Q4 25 | 8.6% | 10.6% | ||
| Q3 25 | 20.9% | 11.1% | ||
| Q2 25 | -18.7% | 2.0% | ||
| Q1 25 | 6.0% | 1.0% | ||
| Q4 24 | -2.8% | 9.7% | ||
| Q3 24 | -16.5% | 9.6% | ||
| Q2 24 | 17.0% | 12.2% | ||
| Q1 24 | -28.5% | 1.2% |
| Q4 25 | 0.2% | 2.0% | ||
| Q3 25 | 0.2% | 1.5% | ||
| Q2 25 | 1.6% | 1.5% | ||
| Q1 25 | 0.2% | 4.7% | ||
| Q4 24 | 0.2% | 2.9% | ||
| Q3 24 | 0.3% | 0.9% | ||
| Q2 24 | 0.9% | 1.1% | ||
| Q1 24 | 1.6% | 3.2% |
| Q4 25 | 9.62× | 2.07× | ||
| Q3 25 | 2.06× | 1.84× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 3.60× | ||
| Q4 24 | -0.27× | 1.54× | ||
| Q3 24 | — | 2.00× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | 1.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
JILL
| Sales Channel Through Intermediary | $80.1M | 53% |
| Sales Channel Directly To Consumer | $70.5M | 47% |
